Comparative Effectiveness of GLP-1 RAs, SGLT2 Inhibitors, and Metformin in Type 2 Diabetes.
Emerging Research,
[S. l.], v. 1, n. 03, p. 20–37, 2025. Disponível em:
https://www.researchemerging.com/index.php/emgr/article/view/10. Acesso em: 4 apr. 2026.